AGP Executive Report
Last update: 2 hours agoHealth Cover: Genki has shortened the minimum term for its worldwide health insurance to one month and expanded preventive and dental benefits. The policy is underwritten by Liechtenstein-based Squarelife Insurance AG. Antifungal Treatment: Strong European sales of Cresemba triggered a $37.5 million milestone payment to Basilea. The medicine is approved for use in Liechtenstein and treats serious fungal infections. Medicine Safety: The European Medicines Agency is reviewing Deanxit, used for depression and anxiety, after reports of potentially persistent movement and cognitive problems. Abortion Law: Liechtenstein’s abortion rules remain largely unchanged after Hereditary Prince Alois vetoed a bill that would have allowed abortion in the first trimester, citing insufficient protection for unborn life.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.